Trial to Compare the Efficacy and Safety of a Single Bolus of TNK-tPA (Tenecteplase, Metalyse®) With Accelerated Infusion of Rt-PA (Alteplase, Actilyse®) in Asian Patients With Acute Myocardial Infarction

NCT00148460 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Myocardial Infarction

Interventions

DRUG: TNK-tPA
DRUG: rt-PA

Sponsor

Boehringer Ingelheim